SASKATOON, Saskatchewan, April 13, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce it has entered into a public listing services agreement (the “Agreement”) with LodeRock Advisors Inc. (“LodeRock”) to provide the Corporation with investor relations services, with a primary focus on developing and executing a 12‑month investor relations strategy, advising senior management on investor‑related matters, and maintaining strong relationships with analysts, investors, and the broader investment community. LodeRock will also serve as the primary investor contact, manage investor messaging and presentation materials, coordinate external reporting with finance teams, and provide timely market intelligence and feedback.